Halina Offner

Title: Halina Offner: Pioneering Innovations in Recombinant Polypeptides

Introduction

Halina Offner is an accomplished inventor based in Portland, OR, known for her significant contributions to the field of recombinant polypeptides. With a total of 8 patents to her name, Offner has been at the forefront of developing innovative methods and compositions aimed at enhancing therapeutic treatments, particularly in the areas of inflammatory diseases and stroke.

Latest Patents

Offner's latest patents include groundbreaking work on recombinant polypeptides that feature modified MHC class II DRα1 domains. These polypeptides are designed to incorporate an antigenic peptide and potentially a linker sequence. They are not only important for understanding the biological function of T-cells but also have pharmaceutical implications, enabling new methods for treating inflammatory diseases.

Another prominent patent focuses on compositions and methods utilizing recombinant MHC molecules for stroke treatment. This innovation employs two-domain MHC polypeptides capable of modulating activities of antigen-specific T-cells. Such advancements may prove instrumental for scenarios requiring detection, purification, or modulation of T-cell activity, especially regarding conditions that lead to central nervous system damage following strokes.

Career Highlights

Throughout her career, Halina Offner has worked with prestigious organizations including Oregon Health & Science University and the United States of America as represented by the Department of Veterans Affairs. Her research has consistently pushed the boundaries of existing knowledge in immunology and therapeutic applications, showcasing her dedication to improving patient outcomes through innovative solutions.

Collaborations

Halina has collaborated with esteemed coworkers like Arthur A. Vandenbark and Gregory G. Burrows. These partnerships have contributed to her successful patent portfolio and have further advanced the field of T-cell modulation and treatment methodologies.

Conclusion

Halina Offner exemplifies the role of an innovative inventor dedicated to advancing medical science. Her contributions through her patents on recombinant polypeptides underscore the potential impacts of her work in treating diseases like stroke and inflammatory conditions. With her continuous research and collaborations, Offner remains a prominent figure in the scientific community, driving forward the frontiers of immunotherapy.